The yfdG gene product is a membrane protein involved in the translocation of glucose linked to bactoprenol . Bactoprenol serves as a lipid carrier that transports glycosyl moieties across the cell membrane during the synthesis of various cell surface structures, including the O-antigen of lipopolysaccharide . The yfdG protein facilitates the movement of glucose across the cytoplasmic membrane, which is a crucial step in synthesizing these structures .
O-antigens are polysaccharides that form the outermost part of the lipopolysaccharide (LPS) layer in Gram-negative bacteria like E. coli . These O-antigens contribute to the bacterium's structural integrity and protect against environmental stressors, including the host's immune system . The yfdG protein plays a role in modifying the O-antigen by translocating glucose, a building block for the polysaccharide chain, across the cell membrane .
The regulation of glucose transport in E. coli is complex, involving catabolite repression (CCR) and inducer exclusion mechanisms . The cAMP-CRP complex, adenylate cyclase (Cya), and the glucose-specific enzyme II (EIICDGlc) play roles in CCR . Additionally, small regulatory RNAs, like SgrS, regulate the abundance of EIICBGlc by influencing the translation of ptsG, which encodes a glucose-specific transporter .
Recombinant protein expression in E. coli is a widely used technique in biotechnology . It involves introducing a gene of interest into E. coli and allowing the bacteria to produce the corresponding protein . The production of recombinant E. coli bactoprenol-linked glucose translocase homolog from prophage CPS-53 (yfdG) can be achieved through this method, which allows for detailed studies of its structure, function, and interactions .
When studying membrane proteins like yfdG, several factors need consideration . The hydrophobic mismatch, where the length of the transmembrane segments does not match the lipid bilayer thickness, can affect protein structure and function . Biophysical factors, such as the distribution of charged amino acids and the free energy of transmembrane segments, also influence protein insertion and stability in the membrane .
Several tools are available to study membrane protein topology . Fusion reporters, such as GFP and alkaline phosphatase, can be used to determine the orientation of protein segments relative to the cytoplasm and periplasm . Protease accessibility assays can also identify exposed loops and transmembrane regions .
This protein is involved in O antigen modification and the translocation of bactoprenol-linked glucose across the cytoplasmic membrane.
KEGG: ecj:JW2346
STRING: 316385.ECDH10B_2513
The yfdG protein (UniProt ID: P77682) is a bactoprenol-linked glucose translocase homolog encoded within the cryptic prophage CPS-53 of Escherichia coli. This 120-amino acid protein is predicted to function in the translocation of glucose molecules across the bacterial membrane using bactoprenol as a carrier lipid . As part of the CPS-53 prophage element, yfdG exists within a prophage region that has been integrated into the bacterial genome over evolutionary time. Cryptic prophages like CPS-53 constitute up to 20% of bacterial genomes and have been shown to provide multiple benefits to host bacteria for surviving adverse environmental conditions . While the specific function of yfdG has not been fully characterized, its homology to glucose translocases suggests involvement in cell envelope biogenesis processes that may contribute to bacterial stress responses or cellular adaptation.
The CPS-53 prophage has been experimentally demonstrated to contribute significantly to bacterial stress resistance. When researchers precisely deleted all nine prophage elements (including CPS-53) from E. coli, they observed decreased resistance to various stressors. Specifically, CPS-53 was found to play a critical role in protecting against oxidative stress, with its deletion almost completely accounting for the increased sensitivity to oxidative damage observed in the prophage-free strain . Although specific proteins from CPS-53 (YfdK, YfdO, and YfdS) have been identified as enhancing resistance to oxidative stress, the contribution of yfdG to stress responses remains a subject for further investigation . The CPS-53 prophage also appears to influence the transcription of key stress response genes including rpoS (encoding the master stress regulator), oxyR (encoding an oxidative stress sensor), and katE (encoding catalase), as their expression was repressed 3-4 fold in the CPS-53 deletion strain compared to wild-type when challenged with hydrogen peroxide .
Bactoprenol (C55-isoprenyl alcohol) is a hydrophobic lipid that plays a crucial role in bacterial cell wall biosynthesis by serving as a carrier molecule that transports peptidoglycan precursors across the cytoplasmic membrane . As a homolog of bactoprenol-linked glucose translocases, yfdG likely participates in a similar mechanism for glucose translocation.
The process would theoretically involve:
Activation of glucose through attachment to a nucleotide donor (typically UDP-glucose)
Transfer of the glucose to bactoprenol phosphate to form bactoprenol-P-P-glucose
Translocation of this complex across the membrane by yfdG
Transfer of glucose to an acceptor molecule on the periplasmic side
Recycling of bactoprenol-pyrophosphate back to bactoprenol phosphate
Researchers investigating this mechanism could employ radiolabeled glucose precursors and membrane vesicle preparations to track the movement of glucose molecules across membranes in the presence and absence of purified yfdG protein. Inhibitor studies using bactoprenol-targeting antibiotics could provide additional insights into the dependency of yfdG function on the bactoprenol carrier system .
For optimal results, researchers should consider using multiple complementary approaches to validate findings. The recombinant protein can be stored at -20°C/-80°C upon receipt, with aliquoting necessary for multiple uses to avoid repeated freeze-thaw cycles . Working aliquots can be stored at 4°C for up to one week, and reconstitution should include glycerol addition for long-term storage stability .
Unlike some other prophages (such as e14, which shows increased excision rates of up to 356-fold under DNA-damaging conditions), CPS-53 maintains its integrated state even when bacteria are exposed to mitomycin C or oxidative stress . This persistent integration ensures that yfdG remains a functional part of the bacterial genome during stress responses, potentially contributing to adaptive advantages.
Researchers interested in studying the impact of prophage stability on yfdG expression could employ the following approaches:
qRT-PCR to measure yfdG transcript levels under various environmental conditions
Reporter gene fusions (e.g., yfdG promoter-GFP) to monitor expression at the single-cell level
Comparison of phenotypes between wild-type strains and engineered strains with CPS-53 precisely deleted
ChIP-seq to identify transcriptional regulators that might control yfdG expression
These methodologies would provide insights into the regulation of yfdG as part of the larger prophage response to environmental conditions.
The CPS-53 prophage encodes multiple proteins that collectively contribute to bacterial physiology and stress responses. While specific interactions between yfdG and other prophage proteins have not been fully characterized, research has identified several CPS-53 proteins with defined functions in stress resistance, particularly YfdK, YfdO, and YfdS, which enhance resistance to oxidative stress .
A comprehensive understanding of yfdG's role within the broader context of CPS-53 function would require:
Protein-protein interaction studies (e.g., bacterial two-hybrid, co-immunoprecipitation)
Comparative phenotypic analysis of strains with individual gene deletions versus the entire prophage deletion
Transcriptomic analysis to identify co-regulated genes within the prophage region
Functional complementation studies to determine which proteins can compensate for each other's functions
It's noteworthy that prophage proteins often work cooperatively to confer benefits to the host bacterium. The collaborative functions of multiple CPS-53 proteins, potentially including yfdG, may explain why CPS-53 contributes significantly to E. coli's resistance to oxidative stress and other environmental challenges .
Bactoprenol-mediated transport systems represent important targets for antibiotics due to their essential role in bacterial cell wall biosynthesis. Several antibiotic compounds disrupt the bactoprenol-mediated transportation pathway, including friulimicin B, nisin, and lantibiotics like NAI-107 . As a homolog of bactoprenol-linked glucose translocases, yfdG might play a role in modifying cell envelope properties that contribute to antibiotic resistance.
Cryptic prophages in E. coli, including CPS-53, have been shown to contribute significantly to resistance against quinolone and β-lactam antibiotics at sub-lethal concentrations . While the specific contribution of yfdG to this resistance has not been directly demonstrated, its putative function in cell envelope modification suggests potential involvement in altering membrane permeability or cell wall structure.
To investigate this possibility, researchers could:
Compare minimum inhibitory concentrations (MICs) of various antibiotics in strains with and without functional yfdG
Analyze changes in cell envelope composition and structure in yfdG-expressing versus yfdG-deleted strains
Investigate potential synergistic effects between yfdG and other prophage-encoded resistance factors
Screen for small molecule inhibitors that specifically target yfdG function and assess their impact on antibiotic susceptibility
Such studies would provide valuable insights into the broader role of prophage-encoded functions in bacterial antibiotic resistance mechanisms.
For researchers planning to work with recombinant yfdG protein, careful consideration of expression and purification conditions is essential. The commercially available recombinant yfdG is expressed in E. coli with an N-terminal His-tag, allowing for purification by metal affinity chromatography . Based on the product information, the following recommendations can be made:
Expression system: E. coli is suitable for expression of the full-length protein (120 amino acids)
Purification method: Ni-NTA affinity chromatography for His-tagged protein
Storage buffer: Tris/PBS-based buffer with 6% trehalose, pH 8.0
Reconstitution: Deionized sterile water to a concentration of 0.1-1.0 mg/mL
Storage: Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C
Working conditions: Store working aliquots at 4°C for up to one week; avoid repeated freeze-thaw cycles
For researchers preparing their own recombinant constructs, designing appropriate expression vectors with removable tags would facilitate both purification and subsequent functional studies. Membrane proteins like yfdG often benefit from expression at lower temperatures (16-25°C) to allow proper folding and membrane insertion.
Evaluating the putative glucose translocase activity of yfdG presents several technical challenges. Researchers can employ the following methodological approaches:
Liposome reconstitution assay:
Purify recombinant yfdG and reconstitute into liposomes
Include fluorescently labeled glucose derivatives or radiolabeled glucose inside liposomes
Measure glucose translocation by monitoring changes in fluorescence or radioactivity
Inverted membrane vesicle preparations:
Prepare inverted membrane vesicles from E. coli expressing yfdG
Monitor ATP-dependent or proton gradient-dependent glucose transport
Bactoprenol-dependent transport assay:
Synthesize bactoprenol-phosphate-glucose substrates
Measure substrate utilization in the presence of purified yfdG and appropriate acceptor molecules
Stopped-flow spectroscopy:
Monitor conformational changes in real-time during substrate binding and transport
Can provide kinetic parameters for the transport process
These techniques require specialized equipment and expertise but offer complementary approaches to characterize the biochemical function of yfdG as a potential glucose translocase.
Despite its identification as a bactoprenol-linked glucose translocase homolog, several fundamental questions about yfdG remain unanswered:
Addressing these questions would significantly advance our understanding of this prophage-encoded protein and its role in bacterial physiology.
Modern high-throughput technologies offer promising avenues for elucidating yfdG function:
| Technology | Application for yfdG Research | Expected Outcomes |
|---|---|---|
| Cryo-electron microscopy | Structural determination | 3D structure revealing membrane topology and potential substrate binding sites |
| Transposon sequencing (Tn-seq) | Identification of genetic interactions | Genes that show synthetic interactions with yfdG under various stress conditions |
| Ribosome profiling | Translation regulation analysis | Changes in yfdG translation efficiency under different growth conditions |
| Metabolomics | Substrate identification | Detection of metabolites affected by yfdG activity |
| ChIP-seq | Identification of regulatory elements | Transcription factors controlling yfdG expression |
Integrating data from these approaches would provide a systems-level understanding of yfdG function within the broader context of bacterial physiology and prophage-host interactions.
Given that bactoprenol-mediated pathways are targeted by several antibiotics and that prophage elements contribute to antibiotic resistance, understanding yfdG function could have implications for antimicrobial development . If yfdG contributes to modifying cell envelope properties that enhance resistance to certain antibiotics, it might represent a novel target for adjuvant therapies that could sensitize bacteria to existing antibiotics.
Research directions with therapeutic potential include:
Screening for specific inhibitors of yfdG function
Evaluating combination therapies targeting both yfdG and conventional antibiotic targets
Investigating whether yfdG inhibition can reverse resistance to bactoprenol-targeting antibiotics
Determining if yfdG contributes to persistence or stress tolerance during antibiotic treatment
These investigations could contribute to addressing the growing challenge of antibiotic resistance in pathogenic bacteria.